94159 ⎘
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
YAP1 INHIBITORS
#2PIPERIDINE COMPOUNDS
#3SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS
#4NANOMATERIALS
#5PENTAMIDINE ANALOGS
#6PIPERAZINE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION
#7Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
#8NOVEL AMINO ACID DERIVATIVES
#9COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY
#10IONIZABLE CATIONIC COMPOUND
#11SWEETENER COMPOSITIONS
#12Charged Ion Channel Blockers and Methods for Use
#13Charged Ion Channel Blockers and Methods for Use
#14SUBSTITUTED VINYL PIPERAZINE-PIPERIDINE UREA DERIVATIVES AS ANTICANCER AGENTS
#15Triester Compounds And Methods Of Use Thereof
#16STAT6 INHIBITORS AND USES THEREOF
#17INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF
#18DUAL LSD1/HDAC INHIBITORS
#19SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE
#20LIPIDIC COMPOUNDS, AND USES THEREOF
#21SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK FOR TREATING CANCER
#22PERIPHERALLY AND LUMINALLY-RESTRICTED INHIBITORS OF THE SEROTONIN TRANSPORTER AS TREATMENTS FOR DISORDERS OF GASTROINTESTINAL MOTILITY AND GUT-BRAIN AXIS
#23SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF
#24IONIZABLE CATIONIC COMPOUND
#25FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF
#26REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
#27OXIMES AND THEIR USE IN TREATMENT OF GBA-RELATED DISEASES
#286-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES
#29MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS
#30CYCLIC LIPIDS AND METHODS OF USE THEREOF
#31HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS
#32PIPERIDINE UREA DERIVATIVES FOR TREATMENT OF NEURODEGENERATIVE DISEASES
#33Substituted nicotinimide inhibitors of BTK for treating cancer
#34Small Molecule Compounds and Compositions
#35Cytotoxic and anti-mitotic compounds, and methods of using the same
#36INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY
#37NANOMATERIALS COMPRISING ESTER-LINKED ACETALS
#38PROBENECID COMPOUNDS FOR THE TREATMENT OF INFLAMMASOME-MEDIATED LUNG DISEASE
#39Diamine derivatives as inhibitors of leukotriene Ahydrolase
#40SULFONYLBENZAMIDE DERIVATIVE AND CONJUGATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF
#41YAP1 inhibitors that target the interaction of YAP1 with OCT4
#42HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
#43Cyclic lipids and methods of use thereof
#44Charged Ion Channel Blockers and Methods for Use
#45Formulations of T-type calcium channel modulators and methods of use thereof
#46FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES
#47N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS
#48RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#49CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF
#50SMYD Inhibitors
#51QUATERNARY HETEROATOM CONTAINING COMPOUNDS
#52AMINO ACID HAVING FUNCTIONAL GROUP CAPABLE OF INTERMOLECULAR HYDROGEN BONDING, PEPTIDE COMPOUND CONTAINING SAME AND METHOD FOR PRODUCTION THEREOF
#53Charged ion channel blockers and methods for use
#54LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS
#55ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#56ERAP1 MODULATORS
#57Polycyclic amines as sigma receptor modulators
#58Method for preparing 1-(1-tert-butoxycarbonyl-4-piperidylacetyl)-4-mesyloxypiperidine and 1-(1-tert-butoxycarbonyl-4-piperidylacetyl)-4-mesyloxypiperidine
#59AGONISTS OF ROR GAMMAt
#60Substituted nicotinimide inhibitors of BTK for treating cancer
#61TERTIARY AMINE DERIVATIVES AND THEIR USES FOR TREATING A VIRAL INFECTION
#62FORMULATIONS OF T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF
#63CYCLIC FORMYL AND CYCLIC KETONE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE
#64Substituted anilines as CCR(4) antagonists
#65INHIBITORS OF CD40-CD154 BINDING
#66NANOPARTICLE, CONTRAST AGENT FOR MAGNETIC RESONANCE IMAGING COMPRISING SAME AND ZWITTERIONIC LIGAND COMPOUND
#67STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF
#68BIARYL DERIVATIVE AS GPR120 AGONIST
#69Formulations of T-type calcium channel modulators and methods of use thereof
#705-HT2A agonists for use in treatment of depression
#71CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE
#72REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
#73Formulations of T-type calcium channel modulators and methods of use thereof
#74Process for the preparation of dexmethyl phenidate hydrochloride
#75YAP1 inhibitors that target the interaction of YAP1 with OCT4
#765-HTagonists for use in treatment of depression
#77INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
#78COMPOSITIONS COMPRISING METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME
#79NANOMATERIALS
#80SMYD INHIBITORS
#81PIPERIDINES AS MENIN INHIBITORS
#82Quaternary heteroatom containing compounds
#835-HTagonists for use in treatment of depression
#84Compositions comprising methylphenidate-prodrugs, processes of making and using the same
#85YAP1 inhibitors that target the interaction of YAP1 with Oct4
#86Lipids and lipid compositions for the delivery of active agents
#87Charged ion channel blockers and methods for use
#88Heterocyclic P2Yreceptor antagonists
#89Cyclopropylamines as LSD1 inhibitors
#90Treatment and prevention of neuropathic pain with P2Y14 antagonists
#91Cyclopropylamines as LSD1 inhibitors
#92Diamide antimicrobial agents
#93CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE
#94ENANTIOSELECTIVE DESTRUCTION OF CHIRAL MOLECULES
#95LSD1 inhibitor and preparation method and application thereof
#96COMPOUND FOR SIMULTANEOUSLY INHIBITING LSD1 AND HDAC TARGETS AND APPLICATION THEREOF
#97Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#98Charged ion channel blockers and methods for use
#99Charged ion channel blockers and methods for use
#100Biguanide compound and use thereof
#101Benzamide derivatives for inhibiting endoplasmic reticulum (ER) stress
#102Processes for the preparation of Niraparib and intermediates thereof
#103Compositions comprising methylphenidate-prodrugs, processes of making and using the same
#104Compositions comprising methylphenidate-prodrugs, processes of making and using the same
#105CYCLOPROPYLAMINES AS LSD1 INHIBITORS
#106Albicidin derivatives, their use and synthesis
#107Quaternary heteroatom containing compounds
#108Substituted anilines as CCR(4) antagonists
#109HISTONE DEACETYLASE INHIBITORS
#110Compositions comprising methylphenidate-prodrugs, processes of making and using the same
#111Methylphenidate-prodrugs, processes of making and using the same
#112S1P modulating agents
#113Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same
#114Compositions comprising methylphenidate-prodrugs, processes of making and using the same
#115Compositions comprising methylphenidate-prodrugs, processes of making and using the same
#116YAP1 inhibitors that target the interaction of YAP1 with OCT4
#117Process for preparing 2-(1-(tert-butoxycarbonyl)piperidine-4-yl)benzoic acid
#118SMYD INHIBITORS
#119Methylphenidate-prodrugs, processes of making and using the same
#120Methylphenidate-prodrugs, processes of making and using the same
#121Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
#122Cytotoxic and anti-mitotic compounds, and methods of using the same
#123Histone deacetylase inhibitors
#124Cyclopropylamines as LSD1 inhibitors
#125INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#126Piperidines as menin inhibitors
#127Methylphenidate-Prodrugs, Processes of Making and Using the Same
#128TETRACYCLINE COMPOUNDS
#1294-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors
#130Cyclopropylamines as LSD1 inhibitors
#131Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#132Lipids and lipid compositions for the delivery of active agents
#133Histone deacetylase inhibitors
#134SIP modulating agents
#135Quaternary heteroatom containing compounds
#136Process for the preparation of fexofenadine and of intermediates used therein
#137Lipids and lipid compositions for the delivery of active agents
#138Polycyclic amines as opioid receptor modulators
#139Charged ion channel blockers and methods for use
#140DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#141Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
#142Substituted anilines as CCR(4) antagonists
#143Inhibitors of leukotriene A4 hydrolase
#144Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors
#145Method of treating Crohn's disease comprising a TLR2 antagonist
#146Stimulant abuse-deterrent compositions
#147Inhibitors of histone deacetylase
#148Hardener composition including 2-(2,2,6,6-tetramethylpiperidin-4-yl)propane-1,3-diamine
#149Heterocyclic modulators of lipid synthesis
#150Biguanide compound and use thereof
#151S1P modulating agents
#152INHIBITORS OF HISTONE DEACETYLASE
#153Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer
#154Biaryl derivative as GPR120 agonist
#155Cyclopropylamines as LSD1 inhibitors
#156Amido compounds and their use as pharmaceuticals
#157Lipids and lipid compositions for the delivery of active agents
#158Enantioselective destruction of chiral molecules
#159INHIBITORS OF HISTONE DEACETYLASE
#160Process for preparation of dexmethylphenidate hydrochloride
#161Cyclopropylamine compounds as histone demethylase inhibitors
#162Cyclopropylamines as LSD1 inhibitors
#163AMINE-CONTAINING LIPIDOIDS AND USES THEREOF
#164LSD1 inhibitors
#165Cyclopropylamines as LSD1 inhibitors
#166Cyclopropylamines as LSD1 inhibitors
#167Immunoregulatory agents
#168Synthetic process
#169ANTIBACTERIAL AGENTS
#170IDENTIFICATION OF COMPOUNDS THAT DISPERSE TDP-43 INCLUSIONS
#171Histone deacetylase inhibitors
#172Methylphenidate-prodrugs, processes of making and using the same
#173Tetracycline compounds
#174Heterocyclic amphoteric compounds
#175Inhibitors of histone deacetylase
#176Substituted benzamides and methods of use thereof
#177Substituted anilines as CCR(4) antagonists
#178Lipids and lipid compositions for the delivery of active agents
#179GLP-1 receptor stabilizers and modulators
#180Hydroxamic acids and uses thereof
#181DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#182Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
#183S1P modulating agents
#184Inhibitors of histone deacetylase
#185Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
#186Compounds useful as immunomodulators
#187HDAC inhibitors
#188Acetylcholinesterase inhibitors and promnesiant serotonin 5-HT4 receptor agonists, their methods of preparation and the pharmaceutical compositions containing the same
#189Aromatic compounds with GPR40 agonistic activity
#190Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#191Heterocyclic amphoteric compounds
#192Methods for preparing d-threo-methylphenidate using diazomethane, and compositions thereof
#193Cytotoxic and anti-mitotic compounds, and methods of using the same
#194Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis
#195S1P modulating agents
#196Procaspase activating compounds
#197Amido compounds and their use as pharmaceuticals
#198Autotaxin inhibitors
#199S1P and/or ATX modulating agents
#200Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof
#201Methylphenidate-prodrugs, processes of making and using the same
#202Process for the preparation of d-threo-ritalinic acid salts via novel salts of intermediate thereof
#203Methods for preparing D-threo methylphenidate using diazomethane, and compositions thereof
#204Potassium channel blockers
#205ATX modulating agents
#206Cyclopropylamines as LSD1 inhibitors
#207Cyclopropylamines as LSD1 inhibitors
#208Cyclopropylamines as LSD1 inhibitors
#209Cyclopropylamines as LSD1 inhibitors
#210SUBSTITUTED CARBAMATE COMPOUNDS
#211ATX modulating agents
#212Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
#213Compounds that are S1P modulating agents and/or ATX modulating agents
#214Antifibrinolytic compounds
#215Cationic lipid
#216Pharmaceutical composition of a papillomavirus inhibitor
#217PROCESS FOR PREPARING 2-[(2E)-2-FLUORO-2-(3-PIPERIDINYLIDENE)ETHYL]-1H-ISOINDOLE-1,3(2H)-DIONE
#218Substituted anilines as CCR(4) antagonists
#219PROCESS FOR THE PREPARATION OF METHYLPHENIDATE AND PHARMACEUTICAL SALTS THEREOF
#220PROCESS FOR THE PREPARATION OF METHYLPHENIDATE AND PHARMACEUTICAL SALTS THEREOF
#221AGRICULTURAL CHEMICALS
#222Cyclic amine derivatives as EPreceptor antagonists
#223Process for the preparation of methylphenidate hydrochloride and its intermediates thereof
#224Low-temperature synthesis of methylphenidate hydrochloride
#225Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein
#226Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use
#227Antibacterial agents
#228Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
#229S1P modulating agents
#230Benzamide derivative and use thereof
#231Allosteric modulators of 5-hydroxytryptamine 2C receptor (5-HT2CR)
#232GLP-1 receptor stabilizers and modulators
#233Cytotoxic and anti-mitotic compounds, and methods of using the same
#234Methylphenidate-oxoacid conjugates, processes of making and using the same
#235Potassium channel blockers
#236Apoptosis promoters
#237Autotaxin inhibitors
#238Amine-containing lipidoids and uses thereof
#239Inhibitors of histone deacetylase
#240Inhibitors of histone deacetylase
#241Identification of compounds that disperse TDP-43 inclusions
#242Trypsin-like serine protease inhibitors, and their preparation and use
#243Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
#244Histone deacetylase inhibitors
#245Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#246Chemical compounds
#247Piperidine derivatives with pesticidal properties
#248N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS
#249Method to prepare beta-functionalized aliphatic esters
#250ACYLATION REACTION OF HYDROXYL GROUP
#251Apoptosis promoters
#252Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
#253Piperidinyl naphthylacetic acids
#254Piperidine derivatives, pharmaceutical compositions and uses thereof
#255Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
#256CETP activity inhibitors
#257METHODS FOR TREATMENT OF COGNITIVE AND MENOPAUSAL DISORDERS WITH D-THREO METHYLPHENIDATE
#258Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
#259Quaternary heteroatom containing compounds
#260NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX
#261CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#262Chemical compounds
#263SUBSTITUTED HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF PAIN AND EPILEPSY
#264SELECTIVE CALCIUM CHANNEL MODULATORS
#265GPCR Agonists
#266Compounds, pharmaceutical compositions and uses thereof
#267Substituted piperidines
#268Tetracycline compounds
#2695-HT RECEPTOR MODULATING COMPOUNDS
#270Resolution of (±)-methyl phenyl[4-[4-[[[4′(trifluoromethyl)-2-biphenylyl]carbonyl]amino]Phenyl]-1-piperidinyl]acetate
#271Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
#272DIACYLETHYLENEDIAMINE COMPOUND
#273Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
#274Chemical compounds
#275Amido compounds and their use as pharmaceuticals
#276Method and compositions for treating amyloid-related diseases
#277Plasma Carboxypeptidase B Inhibitors
#278Trypsin-like serine protease inhibitors, and their preparation and use
#279Process for preparing piper azine derivatives
#280N-acyl anthranilic acid derivative or salt thereof
#281New Compounds VII
#282Polyarylcarboxamides useful as lipid lowering agents
#283High penetration compositions and their applications
#284NOVEL PIPERIDINE-BUTYRAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
#285Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
#286Halogen-containing organosulfur compound and use thereof
#287Apoptosis promoters
#288PIPERIDYLPROPIONAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS INCLUDING DEPRESSION AND PANIC DISORDER
#289PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
#290Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
#291Apoptosis promoters
#292Substituted piperidine compounds and methods of their use
#293COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA
#294Process for the preparation of d-threo-ritalinic acid hydrochloride by resolution of dl-threo-ritalinic acid using chiral carboxylic acid
#295Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors
#296Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
#297Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
#298Benzamide derivatives useful as histone deacetylase inhibitors
#2992-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
#300SUBSTITUTED PIPERIDINYLPROPANOIC ACID COMPOUNDS AND METHODS OF THEIR USE